Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chia-Yen Lin

Showing results (51-60 of 78) with videos related to

Pageof 8
Sort By:
Journal of Cellular and Molecular Medicine|August 3, 2023
Genetic variants of dipeptidyl peptidase IV are linked to the clinicopathologic development of prostate cancerYu-Ching Wen, Chia-Yen Lin, Chi-Hao Hsiao, et al.
Journal of Cellular and Molecular Medicine|March 23, 2024
MAOB expression correlates with a favourable prognosis in prostate cancer, and its genetic variants are associated with the metastasis of the diseaseHsiang-Ching Huang, Yi-Hsien Hsieh, Chi-Hao Hsiao, et al.
Anticancer Research|June 29, 2026
Real-world Comparison of Avelumab Maintenance and Enfortumab Vedotin Plus Pembrolizumab in Metastatic Urothelial CarcinomaTsung-Han Yen, Shian-Shiang Wang, Chaun-Shu Chen, et al.
Frontiers in Immunology|October 20, 2025
Temporal trends in malignancy incidence and outcomes among kidney transplantation recipients: a multi-center real-world evidence study using the TriNetX network (2000-2010 vs. 2010-2021)Gu-Shun Lai, Jian-Ri Li, Chuan-Shu Chen, et al.
Urologic Oncology|June 4, 2019
Genetic polymorphism and carbonic anhydrase 9 expression can predict nodal metastatic prostate cancer risk in patients with prostate-specific antigen levels ≤10 ng/ml at initial biopsyChia-Yen Lin, Shian-Shiang Wang, Cheng-Kuang Yang, et al.
International Journal of Medical Sciences|December 4, 2024
Genetic variants of ADAM9 as potential predictors for biochemical recurrence in prostate cancer patients after receiving a radical prostatectomyYung-Wei Lin, Yu-Ching Wen, Chia-Yen Lin, et al.
In Vivo (Athens, Greece)|October 31, 2023
Influence of Surgical Complications on Outcomes in Kidney Transplantation PatientsGu-Shun Lai, Jian-Ri Li, Shian-Shiang Wang, et al.
Journal of Cancer|September 17, 2025
Potential impact of omentin-1 genetic variants on perineural invasion in prostate cancerWei-Chun Weng, Tien-Huang Lin, Xiu-Yuan He, et al.
Urologic Oncology|September 3, 2019
Functional genetic variant of WW domain containing oxidoreductase gene associated with urothelial cell carcinoma clinicopathologic characteristics and long-term survivalSheng-Chun Hung, Ying-Erh Chou, Jian-Ri Li, et al.
Diagnostics (Basel, Switzerland)|September 4, 2020
Impact of H19 Polymorphisms on Prostate Cancer Clinicopathologic CharacteristicsJu-Chuan Hu, Chia-Yen Lin, Shian-Shiang Wang, et al.
Pageof 8

Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
Journal of Cellular and Molecular Medicine|August 3, 2023
Genetic variants of dipeptidyl peptidase IV are linked to the clinicopathologic development of prostate cancerYu-Ching Wen, Chia-Yen Lin, Chi-Hao Hsiao, et al.
Journal of Cellular and Molecular Medicine|March 23, 2024
MAOB expression correlates with a favourable prognosis in prostate cancer, and its genetic variants are associated with the metastasis of the diseaseHsiang-Ching Huang, Yi-Hsien Hsieh, Chi-Hao Hsiao, et al.
Anticancer Research|June 29, 2026
Real-world Comparison of Avelumab Maintenance and Enfortumab Vedotin Plus Pembrolizumab in Metastatic Urothelial CarcinomaTsung-Han Yen, Shian-Shiang Wang, Chaun-Shu Chen, et al.
Frontiers in Immunology|October 20, 2025
Temporal trends in malignancy incidence and outcomes among kidney transplantation recipients: a multi-center real-world evidence study using the TriNetX network (2000-2010 vs. 2010-2021)Gu-Shun Lai, Jian-Ri Li, Chuan-Shu Chen, et al.
Urologic Oncology|June 4, 2019
Genetic polymorphism and carbonic anhydrase 9 expression can predict nodal metastatic prostate cancer risk in patients with prostate-specific antigen levels ≤10 ng/ml at initial biopsyChia-Yen Lin, Shian-Shiang Wang, Cheng-Kuang Yang, et al.
International Journal of Medical Sciences|December 4, 2024
Genetic variants of ADAM9 as potential predictors for biochemical recurrence in prostate cancer patients after receiving a radical prostatectomyYung-Wei Lin, Yu-Ching Wen, Chia-Yen Lin, et al.
In Vivo (Athens, Greece)|October 31, 2023
Influence of Surgical Complications on Outcomes in Kidney Transplantation PatientsGu-Shun Lai, Jian-Ri Li, Shian-Shiang Wang, et al.
Journal of Cancer|September 17, 2025
Potential impact of omentin-1 genetic variants on perineural invasion in prostate cancerWei-Chun Weng, Tien-Huang Lin, Xiu-Yuan He, et al.
Urologic Oncology|September 3, 2019
Functional genetic variant of WW domain containing oxidoreductase gene associated with urothelial cell carcinoma clinicopathologic characteristics and long-term survivalSheng-Chun Hung, Ying-Erh Chou, Jian-Ri Li, et al.
Diagnostics (Basel, Switzerland)|September 4, 2020
Impact of H19 Polymorphisms on Prostate Cancer Clinicopathologic CharacteristicsJu-Chuan Hu, Chia-Yen Lin, Shian-Shiang Wang, et al.
Pageof 8